|
| Exchange Disseminated Time 18/05/2016 16:09:32 | Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2016, to consider and approve the Quarterly / Yearly Audited Financial Results for the aforesaid Quarter / Year end and to consider recommendation of Dividend, if any on the Equity Shares of the Company.
In view of above, the trading window will remain close for the Promoters, Directors, Insiders, Designated Persons and the Connected Persons from the date of this letter and shall reopen after the expiry of 48 hours from the time the result becomes generally available. |
|
|